Mate, read all my obj posts and you will get the gist...Most were moderated because I posted what most didnt want to hear...I have cautioned against investing in obj since it was 10c, so don't give me the baseless ramping crap... A CR will happen, have a look at revenues for the past 2 years, OBJ will never be cash positive on the current structure and current use of the technology... There is only 5 more quarters of cash left which means there will be a CR when there is around $1m left by the end of the year... Revenues were slightly higher last quarter than the quarter prior but the company used more cash... There is a reason why the company has almost $2b billion shares on its register and that is because they are chasing the dream which the technology cannot support and have been doing so for more than a decade... Nothing will change and this next CR at the low 1c will be a disaster since the last one was at 5.7c... And talking about that last one at 5.7c, the directors raised much more than what was perceived necessary (by the information the directors fed shareholders) because imo, they secretly knew revenues would not increase for a long time if ever...It was a complete disaster yet shareholders believed the spin and stumped up more cash... IMO same thing will happen again, there will be a story of ridiculous revenues to come and they need a few more million to make it happen... Same thing again in 2023...
- Forums
- ASX - By Stock
- Interesting times ahead
Mate, read all my obj posts and you will get the gist...Most...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online